CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-05 | Mahatme Sandesh CFO | Returned to the company | −694,137 | 0 | ||
| 2025-12-05 | Mahatme Sandesh CFO | Grant or award · Employee Stock Option (right to buy) | +1,388,274 | 1,388,274 | ||
| 2025-10-30 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −24,579 | $25.12 | $617K | 779,652 |
| 2025-10-29 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −251,518 | $25.22 | $6.3M | 804,231 |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −87,828 | $27.10 | $2.4M | 1,092,232 |
| 2025-10-28 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −36,483 | $28.18 | $1.0M | 1,055,749 |
| 2025-10-27 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −90,941 | $28.12 | $2.6M | 1,180,060 |
| 2025-10-24 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −53,345 | $28.01 | $1.5M | 1,271,001 |
| 2025-10-23 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −76,880 | $28.01 | $2.2M | 1,324,346 |
| 2025-10-21 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −25,027 | $28.11 | $704K | 1,401,226 |
| 2025-10-21 | Reprogrammed Interchange LLC 10% owner | Sale | −200 | $30.08 | $6K | 1,166,909 |
| 2025-10-20 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −70,366 | $29.63 | $2.1M | 1,432,806 |
| 2025-10-20 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −13,817 | $29.63 | $409K | 1,287 |
| 2025-10-20 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −6,553 | $30.12 | $197K | 1,426,253 |
| 2025-10-20 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −1,287 | $30.12 | $39K | 0 |
| 2025-10-20 | Reprogrammed Interchange LLC 10% owner | Sale | −11,616 | $30.05 | $349K | 1,167,109 |
| 2025-10-17 | Reprogrammed Interchange LLC 10% owner | Sale | −24,689 | $30.22 | $746K | 1,179,753 |
| 2025-10-17 | Reprogrammed Interchange LLC 10% owner | Sale | −1,028 | $31.00 | $32K | 1,178,725 |
| 2025-10-17 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −174,594 | $29.12 | $5.1M | 1,546,621 |
| 2025-10-17 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | −34,284 | $29.12 | $998K | 23,636 |
Page 3 of 18 · 344 trades